DF3/MUC1 signaling in multiple myeloma cells is regulated by interleukin-7

Cancer Biology and Therapy

Volumn 2, Issue 2, 2003, Pages 187-193

  Li, Yongqing ^a   Chen, Wen ^a   Ren, Jian ^a   Yu, Wei Hsuan ^a   Li, Quan ^a   Yoshida, Kiyotsugu ^a   Kufe, Donald ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

IL 7; Lyn; MUC1; Multiple myeloma; catenin

Indexed keywords

BETA CATENIN; CA 15-3 ANTIGEN; CTNNB1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; INTERLEUKIN 7; LYN PROTEIN-TYROSINE KINASE; PRIMER DNA; PROTEIN KINASE LYN; PROTEIN TYROSINE KINASE; RECOMBINANT PROTEIN; TRANSACTIVATOR PROTEIN; TYROSINE;

AMINO ACID SEQUENCE; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; HUMAN; IMMUNOBLOTTING; METABOLISM; MOLECULAR GENETICS; MULTIPLE MYELOMA; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PROTEIN BINDING; SERODIAGNOSIS; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; BETA CATENIN; CA-15-3 ANTIGEN; CYTOSKELETAL PROTEINS; DNA PRIMERS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOBLOTTING; INTERLEUKIN-7; MOLECULAR SEQUENCE DATA; MULTIPLE MYELOMA; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PRECIPITIN TESTS; PROTEIN BINDING; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED; TYROSINE;

EID: 11144240877     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.2.2.282     Document Type: Article

References (40)

1. Kufe D, Inghirami G, Abe M, Hayes D, Justi-Wheeler H, Schlom J. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 1984; 3:223-32. (Pubitemid 15184701)
2. Takahashi T, Makiguchi Y, Hinoda Y, Kakiuchi H, Nakagawa N, Imai K, et al. Expression of MUC-1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient. J Immunol 1994; 153:2102-9. (Pubitemid 24256681)
3. Ligtenberg M, Buijs F, Vos H and Hilkens J. Suppression of cellular aggregation by high levels of episialin. Cancer Res. 1992; 52:223-32.
4. Gendler S, Taylor-Papadimitriou J, Duhig T, Rothbard J, Burchell JA. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J Biol Chem 1988; 263:12820-3.
5. Siddiqui J, Abe M, Hayes D, Shani E, Yunis E and Kufe D. Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc Natl Acad Sci USA 1988; 85:2320-3. (Pubitemid 24315883)
6. Yamamoto M, Bharti A, Li Y and Kufe D. Interaction of the DF3/MUC1 breast carcinoma-associated antigen and β-catenin in cell adhesion. J Biol Chem 1997; 272:12492-4. (Pubitemid 27203339)
7. Li Y, Bharti A, Chen D, Gong J and Kufe D. Interaction of glycogen synthase kinase 3β with the DF3/MUC1 carcinoma-associated antigen and β-catenin. Mol Cell Biol 1998; 18:7216-24. (Pubitemid 28533041)
8. Li Y, Kuwahara H, Ren J, Wen G and Kufe D. The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3β and β-catenin. J Biol Chem 2001; 276:6061-4.
9. Dyomin VG, Palanisamy N, Lloyd KO, Dyomina K, Jhanwar SC, Houldsworth J, et al. MUC1 is activated in a B-cell lymphoma by the t(1;14)(q21;q32) translocation and is rearranged and amplified in B-cell lymphoma subsets. Blood 2000; 95:2666-71. (Pubitemid 30210548)
10. Treon SP, Mollick JA, Urashima M, Teoh G, Chauhan D, Ogata A, et al. Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasone. Blood 1999; 93:1287-98. (Pubitemid 29076144)
11. Delsol G, Gatter KC, Stein H, Erber WN, Pulford KA, Zinne K, et al. Human lymphoid cells express epithelial membrane antigen. Implications for diagnosis of human neoplasms. Lancet 1984; 2:1124-9.
12. Yamanashi Y, Kakiuchi T, Mizuguchi J, Yamamoto T and Toyoshima K. Association of B cell antigen receptor with protein tyrosine kinase lyn. Science 1991; 251:192-4 (Pubitemid 21916867)
13. Saouaf SJ, Kut SA, Fargnoli J, Rowley RB, Bolen JB and Mahajan S. Reconstitution of the B cell antigen receptor signaling components in COS cells. J Biol Chem 1995; 270:27072-8.
14. Johnson SA, Pleiman CM, Pao L, Schneringer J, Hippen K and Cambier JC. Phosphorylated immunoreceptor signaling motifs (ITAMs) exhibit unique abilities to bind and activate Lyn and Syk tyrosine kinases. J Immunol 1995; 155:4596-603.
15. Rowley R, Burkhardt A, Chao H, Matsueda G and Bolen J. Syk protein-tyrosine kinase is regulated by tyrosine-phosphorylated Igα/Igβ immunoreceptor tyrosine activation motif binding and autophosphorylation. J Biol Chem 1995; 270:11590-4.
16. Seckinger P and Fougereau M. Activation of src family kinases in human pre-B cells by IL- 7. J Immunol 1994; 153:97-109. (Pubitemid 24186522)
17. Namen AE, Lupton S, Hjerrild KJ, Wignall J, Mochizuki DY, Schmierer A, et al. Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 1988; 333:571-3.
18. Goodwin RG, Lupton S, Schmierer A, Hjerrild KJ, Jerzy R, Clevenger W, et al. Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells. Proc Natl Acad Sci USA 1989; 86:302-6. (Pubitemid 19036374)
19. Clark SG, Stern MJ and Horowitz HR. C. elegans cell-signaling gene sem-5 encodes a protein with SH2 and SH3 domains. Nature 1992; 356:340-4.
20. Nishizumi H, Taniuchi I, Yamanashi Y, Kitamura D, IIic D, Mori S, et al. Impaired proliferation of peripheral B cells and indication of autoimmune disease in Lyn-deficient mice. Immunity 1995; 1:549-60.
21. Nishizumi H, Horikawa K, Mlinaric-Rascan I and Yamamoto T. A double-edged kinase lyn: A positive and negative regulator for antigen receptor-mediated signals. J Exp Med 1998; 187:1343-8. (Pubitemid 28189123)
22. Schroeder J, Thompson M, Gardner M and Gendler S. Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland. J Biol Chem 2001; 276:13057-64.
23. Yoshida K, Kharbanda S and Kufe D. Functional interaction between SHPTP1 and the Lyn tyrosine kinase in the apoptotic response to DNA damage. J Biol Chem 1999; 274:34663-8. (Pubitemid 129509504)
24. Li Y, Ren J, Yu W-H, Li G, Kuwahara H, Yin L, et al. The EGF receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and β-catenin. J Biol Chem 2001; 276:35239-42.
25. Behrens J, von Kries JP, Kühl M, Bruhn L, Wedlich D, Grosschedi R, et al. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 1996; 382:638-42. (Pubitemid 26268958)
26. Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, Korinek V, et al. Tcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell 1996; 86:391-9. (Pubitemid 26272079)
27. Brunner E, Peter O, Schweizer L, Basler K. Pangolin encodes a Lef-1 homologue that acts downstream of Armadillo to transduce the Wingless signal in Drosophila. Nature 1997; 385:829-33. (Pubitemid 27106074)
28. Merlo G, Siddiqui J, Cropp C, Liscia DS, Lidereau R, Callahan R, et al. DF3 tumor-associated antigen gene is located in a region on chromosome 1q frequently altered in primary human breast cancer. Cancer Res. 1989; 49:6966-71. (Pubitemid 20016576)
29. Hofmeister R, Khaled A, Benbernou N, Rajnavolgyi E, Muegge K, Durum S. Interleukin- 7: physiological roles and mechanisms of action. Cytokine & Growth Factor Reviews 1999; 10:41-60. (Pubitemid 29230851)
30. Prieyl J and LeBien T. Interleukin-7 independent development of human B cells. Proc Natl Acad Sci USA 1996; 93:10348-53.
31. Tan JT, Dudl E, LeRoy E, Murray R, Sprent J, Weinberg KI, et al. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci USA 2001; 98:8732-7. (Pubitemid 32678096)
32. Hernandez-Caselles T, Martinez-Esparza M, Sancho D, Rubio G, Aparicio P. Interleukin- 7 rescues human activated T lymphocytes from apoptosis induced by glucocorticosteroids and regulates bcl-2 and CD25 expression. Human Immunol 1995; 43:181-9.
33. Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain SH, Masiarz FR, et al. Association of the APC gene product with β-catenin. Science 1993; 262:1731-1734 (Pubitemid 24030096)
34. Su L-K, Vogelstein B and Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993; 262:1734-7. (Pubitemid 24030097)
35. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S and Polakis P. Binding of GSK3- to the APC-β-catenin complex and regulation of complex assembly. Science 1996; 272:1023-6. (Pubitemid 26259322)
36. Aberie H, Bauer A, Stappert J, Kispert A, Kemler R. β-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997; 16:3797-804.
37. Orford K, Crockett C, Jensen J, Weissman A and Byers S. Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J Biol Chem 1997; 272:24735-8. (Pubitemid 27415637)
38. Solomon D, Sacco P, Roy S, Simcha I, Johnson K, Wheelock M, et al. Regulation of beta-catenin levels and localization by overexpression of plakoglobin and inhibition of the ubiquition- proteasome system. J Cell Biol 1997; 139:1325-35. (Pubitemid 27523218)
39. Takeichi M. Cadherins: a molecular family important in selective cell-cell adhesion. Ann Rev Biochem 1990; 59:237-52.
40. Kramps T, Peter O, Brunner E, Nellen D, Froesch B, Chatterjee S, et al. Wnt/Wingless signaling requires Bcl9/legless-mediated recruitment of pygopus to the nuclear beat-catenin- TCF complex. Cell 2002; 189:47-60. (Pubitemid 34327516)